Dosing Calculation Formula

Comprehensive Guide to Dosing Calculation Formula

Module A: Introduction & Importance

Dosing calculation formulas represent the cornerstone of safe and effective medication administration in clinical practice. These mathematical frameworks ensure patients receive the precise amount of medication needed for therapeutic benefit while minimizing the risk of adverse effects. The importance of accurate dosing cannot be overstated – according to a FDA report, medication errors affect over 7 million patients annually in the United States alone, with incorrect dosing being a primary contributor.

The dosing calculation process involves multiple variables including patient weight, medication potency, administration route, and treatment duration. Healthcare professionals must consider:

• Pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes drugs)
• Pharmacodynamics (the drug’s biochemical and physiological effects)
• Therapeutic index (the ratio between toxic and therapeutic doses)
• Patient-specific factors (age, weight, renal/hepatic function, genetic factors)

Modern dosing calculations have evolved from simple weight-based formulas to sophisticated algorithms incorporating:

1. Body surface area calculations for chemotherapy agents
2. Renal function adjustments using creatinine clearance
3. Loading dose calculations for rapid therapeutic levels
4. Maintenance dose calculations for sustained therapy
5. Pediatric and geriatric dosing adjustments

Module B: How to Use This Calculator

Our precision dosing calculator simplifies complex pharmaceutical calculations while maintaining clinical accuracy. Follow these steps for optimal results:

1. Enter Patient Weight: Input the patient’s current weight in kilograms. For pediatric patients, use the most recent accurate measurement. For adults, use the adjusted body weight if the patient is obese (IBW + 0.4 × (actual weight – IBW)).
2. Specify Medication Dose: Enter the prescribed dosage in mg/kg. This information is typically found in the drug’s prescribing information or clinical guidelines. For example, amoxicillin is commonly prescribed at 20-40 mg/kg/day for children.
3. Select Administration Frequency: Choose how often the medication should be administered daily. Common frequencies include:
   • Once daily (QD) – often used for extended-release formulations
   • Twice daily (BID) – common for many antibiotics and antihypertensives
   • Three times daily (TID) – typical for some pain medications
   • Four times daily (QID) – used for medications with short half-lives
4. Set Treatment Duration: Input the number of days the medication should be administered. Standard courses vary by condition:
   • Antibiotics: Typically 7-14 days
   • Steroids: Often tapered over 5-14 days
   • Pain medications: Usually 3-7 days for acute pain
   • Chronic medications: May be indefinite
5. Choose Administration Route: Select how the medication will be delivered:
   • Oral – most common for outpatient treatment
   • Intravenous – used for rapid effect or when oral route is unavailable
   • Intramuscular – often used for vaccines and some antibiotics
   • Topical – for localized treatment of skin conditions
6. Review Results: The calculator will display:
   • Single dose amount in milligrams
   • Total daily dosage
   • Complete course dosage
   • Visual representation of the dosing schedule
7. Clinical Verification: Always cross-reference results with:
   • Drug prescribing information
   • Clinical practice guidelines
   • Patient’s medical history and current medications
   • Institutional protocols and formularies

Pro Tip: For medications with narrow therapeutic indices (e.g., digoxin, warfarin, lithium), consider using our advanced pharmacokinetic calculator for more precise dosing based on patient-specific factors.

Module C: Formula & Methodology

The dosing calculation formula employed in this tool follows evidence-based pharmacological principles. The core calculation uses the following mathematical framework:

Single Dose (mg) = Patient Weight (kg) × Dose (mg/kg)

Daily Total (mg) = Single Dose × Frequency

Total Course (mg) = Daily Total × Duration (days)

However, the actual implementation incorporates several sophisticated adjustments:

1. Weight-Based Dosing Adjustments

For patients at weight extremes, the calculator applies:

• Pediatric patients: Uses actual body weight for most medications, with exceptions for drugs where body surface area is more appropriate (e.g., chemotherapy)
• Obese patients (BMI ≥ 30): Automatically applies adjusted body weight calculation for most medications, using ideal body weight for drugs that distribute primarily in lean tissue (e.g., gentamicin)
• Underweight patients: Flags potential malnutrition concerns when BMI < 18.5

2. Frequency-Based Distribution

The calculator accounts for pharmacodynamic properties by:

Frequency	Typical Use Cases	Pharmacokinetic Considerations
Once Daily (QD)	Extended-release formulations, medications with long half-lives (>24 hours)	Steady-state reached in ~5 half-lives; ideal for drugs with wide therapeutic index
Twice Daily (BID)	Most antibiotics, many antihypertensives, some analgesics	Maintains therapeutic levels with 12-hour dosing intervals; common for drugs with 8-16 hour half-lives
Three Times Daily (TID)	Pain medications, some anti-infectives, gastrointestinal drugs	8-hour dosing interval helps maintain consistent blood levels for drugs with 6-12 hour half-lives
Four Times Daily (QID)	Short-acting medications, some ophthalmic solutions	6-hour dosing for drugs with very short half-lives (<6 hours); may affect patient compliance

3. Route-Specific Considerations

Bioavailability varies significantly by administration route:

Route	Typical Bioavailability	Dosing Adjustments	Common Examples
Oral	5-100% (varies by drug)	Oral dose = IV dose / bioavailability	Amoxicillin (90%), Morphine (20-40%)
Intravenous	100%	No adjustment needed for bioavailability	Vancomycin, Heparin, Most chemotherapy
Intramuscular	75-100%	Generally similar to IV dosing	Vaccines, Some antibiotics, Epinephrine
Topical	Minimal systemic absorption	Dosing based on surface area treated	Corticosteroids, Antifungals, Local anesthetics

4. Duration Considerations

The calculator incorporates duration-based adjustments:

• Short courses (<7 days): No cumulative effect calculations needed
• Medium courses (7-30 days): Flags potential for cumulative toxicity with certain medications
• Long courses (>30 days): Recommends therapeutic drug monitoring for narrow-index drugs
• Indefinite therapy: Suggests regular renal/hepatic function monitoring

Module D: Real-World Examples

Case Study 1: Pediatric Amoxicillin Prescription

Patient: 5-year-old male, 20 kg, diagnosed with acute otitis media

Medication: Amoxicillin 40 mg/kg/day in divided doses BID for 10 days

Calculation:

• Daily dose: 20 kg × 40 mg/kg = 800 mg
• Single dose: 800 mg ÷ 2 = 400 mg
• Total course: 800 mg × 10 days = 8000 mg

Clinical Considerations: The calculator would flag that amoxicillin suspension comes in 125 mg/5 mL and 250 mg/5 mL concentrations, suggesting the 250 mg/5 mL (8 mL per dose) for easier administration.

Case Study 2: Adult Vancomycin Dosing

Patient: 45-year-old female, 70 kg, normal renal function (CrCl 90 mL/min), hospitalized with MRSA pneumonia

Medication: Vancomycin 15 mg/kg IV Q12H

Calculation:

• Single dose: 70 kg × 15 mg/kg = 1050 mg
• Daily dose: 1050 mg × 2 = 2100 mg
• Loading dose recommendation: 25 mg/kg = 1750 mg (one-time)

Clinical Considerations: The calculator would recommend:

• Therapeutic drug monitoring with trough levels
• Renal function monitoring every 48 hours
• Infusion over at least 60 minutes to reduce “red man syndrome” risk

Case Study 3: Geriatric Warfarin Initiation

Patient: 78-year-old male, 68 kg, atrial fibrillation, CHA₂DS₂-VASc score 4

Medication: Warfarin initial dose 5 mg daily (typical geriatric starting dose)

Calculation:

• Initial dose: 5 mg daily (not weight-based for warfarin)
• Maintenance dose typically 2-10 mg/day based on INR monitoring

Clinical Considerations: The calculator would emphasize:

• INR monitoring every 2-3 days initially
• Drug interactions with common medications (e.g., amiodarone, antibiotics)
• Dietary vitamin K consistency
• Falls risk assessment due to bleeding risk

Module E: Data & Statistics

Comparison of Dosing Errors by Healthcare Setting

Healthcare Setting	Error Rate per 1000 Doses	Most Common Error Types	Prevention Strategies
Hospital Inpatient	5.3	Wrong dose (42%), wrong time (28%), omitted dose (18%)	Barcode medication administration, clinical decision support, pharmacist verification
Outpatient Clinic	3.7	Wrong dose (35%), wrong drug (25%), wrong instructions (20%)	E-prescribing with dose checking, patient counseling, prescription review
Long-Term Care	8.1	Omitted dose (38%), wrong time (30%), wrong dose (22%)	Automated dispensing cabinets, regular medication reviews, staff education
Home Healthcare	6.5	Wrong dose (45%), wrong technique (30%), wrong frequency (15%)	Patient/caregiver education, simplified regimens, home visits by nurses
Emergency Department	4.2	Wrong dose (50%), wrong drug (25%), wrong route (15%)	Pre-mixed emergency drugs, weight-based dosing charts, double-check systems

Medication Classes with Highest Error Rates

Medication Class	Error Rate per 1000 Doses	Common Error Types	High-Risk Patient Populations
Anticoagulants	12.4	Wrong dose (60%), wrong frequency (25%), monitoring errors (10%)	Elderly, patients with renal impairment, those on multiple interacting medications
Insulin	10.8	Wrong dose (55%), wrong type (30%), administration errors (10%)	Diabetic patients, those with varying nutritional intake, hospitalized patients
Opioid Analgesics	9.7	Wrong dose (45%), wrong frequency (30%), wrong route (15%)	Post-surgical patients, chronic pain patients, opioid-naïve individuals
Chemotherapy Agents	8.3	Wrong dose (70%), wrong rate (20%), preparation errors (5%)	Oncology patients, those with rapidly changing weight, patients with organ dysfunction
Antibiotics	7.2	Wrong dose (40%), wrong frequency (35%), wrong duration (15%)	Pediatric patients, elderly, immunocompromised individuals
Electrolytes	6.9	Wrong dose (50%), wrong rate (30%), wrong concentration (15%)	Patients with renal failure, those with fluid/electrolyte imbalances, ICU patients

Data sources: Institute for Safe Medication Practices and Agency for Healthcare Research and Quality

Module F: Expert Tips

Dosing Calculation Best Practices

1. Always double-check weight measurements:
   • Use calibrated scales for accurate weight
   • For pediatric patients, use length-based tapes when weight is unavailable
   • Consider weight changes due to fluid status (edema, dehydration)
2. Understand drug-specific considerations:
   • Some drugs use ideal body weight (e.g., aminoglycosides)
   • Others use adjusted body weight (e.g., vancomycin)
   • Pediatric drugs may use body surface area (e.g., chemotherapy)
3. Account for organ function:
   • Use Cockcroft-Gault or MDRD for renal function assessment
   • Child-Pugh score for hepatic impairment
   • Adjust doses for both renal and hepatic dysfunction when applicable
4. Consider pharmacokinetic principles:
   • Loading doses for rapid therapeutic levels
   • Maintenance doses for steady-state concentrations
   • Half-life considerations for dosing intervals
5. Use technology wisely:
   • Verify calculator results with manual calculations
   • Check for drug interaction alerts in your EHR system
   • Use barcode medication administration when available
6. Document thoroughly:
   • Record weight used for calculations
   • Document dosing rationale in patient notes
   • Note any adjustments made for organ function
7. Monitor and adjust:
   • Schedule appropriate lab monitoring (e.g., INR for warfarin)
   • Assess for therapeutic response and adverse effects
   • Adjust doses based on clinical response and lab values

Common Pitfalls to Avoid

• Unit confusion: Always verify whether dose is in mg, mcg, or other units. The calculator helps prevent this by standardizing to mg/kg.
• Decimal errors: Never use trailing zeros (write “5 mg” not “5.0 mg”) and always use leading zeros (write “0.5 mg” not “.5 mg”).
• Route assumptions: Don’t assume oral and IV doses are equivalent – bioavailability differs significantly.
• Pediatric assumptions: Never assume adult doses can be simply reduced for children – pediatric pharmacokinetics differ substantially.
• Geriatric oversights: Don’t forget that elderly patients often have reduced renal/hepatic function even with normal serum creatinine.
• Obese patient errors: Avoid using actual body weight for all medications in obese patients – some drugs require ideal or adjusted body weight.
• Monitoring neglect: Don’t prescribe medications requiring monitoring (e.g., warfarin, digoxin) without planning for appropriate follow-up.

Advanced Techniques

• Therapeutic Drug Monitoring (TDM):
  • Essential for drugs with narrow therapeutic indices
  • Common TDM medications: vancomycin, aminoglycosides, digoxin, lithium, phenytoin
  • Typically requires trough levels (just before next dose) and sometimes peak levels
• Pharmacogenetic Testing:
  • Can identify patients who metabolize drugs unusually fast or slow
  • Common tests: CYP2D6 for codeine/tramadol, CYP2C19 for clopidogrel, HLA-B*5701 for abacavir
  • Can prevent adverse drug reactions and treatment failures
• Population Pharmacokinetics:
  • Uses mathematical models based on patient populations
  • Can predict drug behavior in specific patient groups
  • Particularly useful for drugs with high interpatient variability
• Bayesian Dosing:
  • Combines population data with patient-specific information
  • Allows for individualized dosing adjustments
  • Requires specialized software but can significantly improve outcomes

Module G: Interactive FAQ

How does patient weight affect medication dosing?

Patient weight is one of the most critical factors in dosing calculations because:

• Distribution volume: Many drugs distribute throughout body water or fat, so dose must scale with body size
• Metabolic capacity: Larger patients generally have greater liver enzyme activity
• Renal clearance: Kidney function typically scales with body size
• Surface area: Some drugs (especially chemotherapy) dose based on body surface area which correlates with metabolic rate

For obese patients, we use adjusted body weight for most medications to avoid overdosing, calculated as:

Adjusted Body Weight = Ideal Body Weight + 0.4 × (Actual Weight – Ideal Body Weight)

Ideal body weight is calculated using the Devine formula:

• Male: 50 kg + 2.3 kg × (height in inches – 60)
• Female: 45.5 kg + 2.3 kg × (height in inches – 60)

What’s the difference between loading doses and maintenance doses?

Loading doses and maintenance doses serve different pharmacological purposes:

Characteristic	Loading Dose	Maintenance Dose
Purpose	Achieve therapeutic concentration quickly	Maintain therapeutic concentration
Size	Typically larger than maintenance dose	Smaller, repeated doses
Frequency	Given once or few times at therapy initiation	Given at regular intervals
Calculation Basis	Based on volume of distribution (Vd)	Based on clearance (Cl) and desired steady-state concentration
Formula	Loading Dose = (Cp × Vd) / F	Maintenance Dose = (Cp × Cl × τ) / F
Common Examples	Digoxin, phenytoin, aminoglycosides, warfarin	Most chronic medications (e.g., antihypertensives, antiepileptics)
Time to Steady State	Immediate therapeutic levels	Typically 4-5 half-lives to reach steady state

Where:

• Cp = target plasma concentration
• Vd = volume of distribution
• Cl = clearance
• τ = dosing interval
• F = bioavailability (for oral drugs)

How do I calculate doses for patients with renal impairment?

Renal impairment significantly affects drug clearance. Follow this step-by-step approach:

1. Assess renal function:
   • Calculate creatinine clearance (CrCl) using Cockcroft-Gault equation:

     Male: CrCl = (140 – age) × weight (kg) × 1.23 / serum creatinine (μmol/L)

     Female: CrCl = 0.85 × male value

   • Alternatively, use MDRD or CKD-EPI equations for GFR estimation
2. Determine drug’s renal elimination:
   • Check drug monograph for % renal elimination
   • Drugs with >30% renal elimination typically require adjustment
3. Consult dosing guidelines:
   • Use institution-specific renal dosing protocols
   • Refer to resources like the Renal Pharmacy Consultants database
4. Adjust dose based on CrCl/GFR:

   Renal Function	CrCl (mL/min)	Typical Dose Adjustment
   Normal	>80	No adjustment needed
   Mild impairment	50-80	Reduce dose by 25% or increase interval by 1.5×
   Moderate impairment	30-50	Reduce dose by 50% or double the interval
   Severe impairment	10-30	Reduce dose by 75% or use 3-4× normal interval
   End-stage renal disease	<10	Avoid if possible; if essential, use 10-25% of normal dose with extended intervals

5. Monitor closely:
   • Therapeutic drug monitoring for narrow-index drugs
   • Regular renal function tests
   • Assessment for drug toxicity signs

Important exceptions: Some drugs (e.g., insulin, warfarin) don’t require renal dose adjustments despite being partially renally cleared, as their effects are monitored clinically.

What are the most common dosing errors and how can I prevent them?

The most frequent dosing errors in clinical practice include:

1. Tenfold errors (10× overdoses/under doses):
   • Cause: Misplaced decimal points, confusion between mg and mcg
   • Prevention: Always have second clinician verify calculations
   • Use tall man lettering (e.g., “mG” vs “mCg”)
2. Wrong patient errors:
   • Cause: Similar patient names, rushed workflow
   • Prevention: Use two patient identifiers (name + DOB/MRN)
   • Implement barcode medication administration
3. Omitted doses:
   • Cause: Forgetfulness, medication unavailability
   • Prevention: Use medication reminders and pill organizers
   • Implement automated dispensing systems in hospitals
4. Wrong time errors:
   • Cause: Poor scheduling, shift changes
   • Prevention: Standardize administration times (e.g., 0900, 1700)
   • Use electronic medication administration records
5. Wrong dose form:
   • Cause: Confusion between immediate-release and extended-release
   • Prevention: Clearly label all medications
   • Store different formulations separately
6. Improper crushing/splitting:
   • Cause: Not checking if tablet can be crushed/split
   • Prevention: Consult drug monographs before altering dose forms
   • Use liquid formulations when appropriate
7. Incorrect rate of administration:
   • Cause: Misreading infusion rates, pump programming errors
   • Prevention: Double-check infusion calculations
   • Use smart pumps with dose error reduction systems

System-level prevention strategies:

• Implement computerized physician order entry (CPOE) with clinical decision support
• Standardize dosing protocols and order sets
• Provide regular staff education on high-alert medications
• Encourage a culture of reporting and learning from errors
• Use independent double-checks for high-risk medications

How do I calculate doses for pediatric patients?

Pediatric dosing requires special considerations due to developmental changes in pharmacokinetics:

Key Principles:

• Weight-based dosing: Most common method using mg/kg
• Body surface area (BSA): Used for chemotherapy and some other drugs
• Age-based dosing: Sometimes used when weight isn’t available
• Developmental pharmacokinetics: Drug absorption, distribution, metabolism, and excretion change with age

Weight-Based Dosing:

Most pediatric medications use weight-based dosing with the formula:

Dose = Patient Weight (kg) × Dose (mg/kg)

Example: Amoxicillin 40 mg/kg/day in divided doses BID for a 10 kg child:

• Daily dose: 10 kg × 40 mg/kg = 400 mg
• Single dose: 400 mg ÷ 2 = 200 mg

Body Surface Area (BSA) Dosing:

Used for drugs with narrow therapeutic index or when dose correlates better with BSA than weight. Calculate BSA using the Mosteller formula:

BSA (m²) = √[Height (cm) × Weight (kg) / 3600]

Example: Methotrexate 100 mg/m² for a child with height 110 cm and weight 20 kg:

• BSA = √(110 × 20 / 3600) = √0.611 = 0.78 m²
• Dose = 0.78 × 100 = 78 mg

Age-Specific Considerations:

Age Group	Pharmacokinetic Considerations	Dosing Adjustments
Neonates (0-1 month)	Reduced renal function (GFR ~30% of adult) Reduced hepatic enzyme activity Increased extracellular water	Extended dosing intervals Lower initial doses Close monitoring required
Infants (1-12 months)	Rapidly maturing renal/hepatic function Increased body water percentage Variable protein binding	Weight-based dosing with frequent adjustments Consider postmenstrual age for preterm infants
Toddlers (1-5 years)	High metabolic rate Variable absorption due to erratic eating Rapid growth phases	Divided doses to maintain compliance Liquid formulations preferred
School-age (6-12 years)	Pharmacokinetics approach adult values Body composition changes Increasing ability to swallow tablets	Can often use adult dosing adjusted for weight Transition from liquids to tablets when possible
Adolescents (13-18 years)	Pharmacokinetics similar to adults Hormonal changes may affect drug metabolism Compliance issues common	Adult doses often appropriate Consider compliance when selecting formulations

Pediatric-Specific Resources:

• FDA Pediatric Dosing Handbook
• ASHP Pediatric Pharmacotherapy Resources
• Harriet Lane Handbook (standard pediatric reference)
• NeoFax (neonatal dosing reference)

What special considerations apply to geriatric patients?

Geriatric patients (typically ≥65 years) require careful dosing considerations due to:

Physiological Changes Affecting Pharmacokinetics:

Pharmacokinetic Parameter	Age-Related Changes	Dosing Implications
Absorption	Reduced gastric acidity Slower gastric emptying Reduced intestinal blood flow	May need to adjust doses of drugs requiring acidic environment Consider sublingual or parenteral routes when absorption is problematic
Distribution	Reduced total body water Increased fat-to-muscle ratio Reduced serum albumin	Water-soluble drugs may reach higher concentrations Fat-soluble drugs may have prolonged effects Increased free drug fraction for highly protein-bound drugs
Metabolism	Reduced liver mass and blood flow Decreased phase I metabolism (CYP450) Relatively preserved phase II metabolism	Reduce doses of drugs metabolized by CYP450 enzymes Monitor for drug interactions Consider alternative drugs with non-hepatic clearance
Excretion	Reduced renal mass and blood flow Decreased GFR (declines ~1% per year after age 40) Reduced tubular secretion	Adjust doses for all renally cleared drugs Monitor renal function regularly Consider GFR estimation equations for elderly

Geriatric Dosing Principles:

• Start low, go slow: Begin with lower initial doses and titrate gradually
• Simplify regimens: Minimize number of doses and medications (aim for ≤5 medications)
• Avoid anticholinergics: High risk of cognitive impairment, falls, and urinary retention
• Monitor closely: Regular assessment for adverse drug reactions and drug-drug interactions
• Consider frailty: Use clinical frailty scales to guide dosing in vulnerable elderly
• Review regularly: Conduct comprehensive medication reviews at least annually

High-Risk Medications in Geriatrics:

The American Geriatrics Society Beers Criteria identifies medications that are potentially inappropriate for older adults:

Medication Class	Examples	Risks in Elderly	Safer Alternatives
Benzodiazepines	Diazepam, alprazolam, lorazepam	Cognitive impairment, falls, fractures	Non-pharmacologic therapies, shorter-acting agents if needed
Anticholinergics	Diphenhydramine, oxybutynin, tricyclic antidepressants	Delirium, cognitive decline, urinary retention	Peripheral-acting anticholinergics, non-anticholinergic alternatives
NSAIDs	Ibuprofen, naproxen, indomethacin	GI bleeding, renal failure, HTN exacerbation	Acetaminophen, topical agents, physical therapy
Skeletal muscle relaxants	Cyclobenzaprine, methocarbamol	Sedation, fractures, anticholinergic effects	Physical therapy, heat/ice therapy
First-generation antihistamines	Diphenhydramine, chlorpheniramine	Sedation, anticholinergic effects, cognitive impairment	Second-generation antihistamines (loratadine, cetirizine)
Long-acting sulfonylureas	Glyburide, chlorpropamide	Prolonged hypoglycemia	Short-acting agents (glipizide), metformin, DPP-4 inhibitors

Geriatric Assessment Tools:

• Beers Criteria: List of potentially inappropriate medications for older adults
• STOPP/START Criteria: Screening Tool of Older Persons’ Prescriptions and Screening Tool to Alert to Right Treatment
• MAI (Medication Appropriateness Index): Evaluates appropriateness of each medication
• Frailty Index: Assesses vulnerability to adverse outcomes

How does liver disease affect medication dosing?

Liver disease can significantly alter drug metabolism, requiring careful dose adjustments. The liver’s role in drug processing includes:

Hepatic Drug Metabolism:

• Phase I reactions: Oxidation, reduction, hydrolysis (primarily by cytochrome P450 enzymes)
• Phase II reactions: Conjugation (glucuronidation, acetylation, sulfation)
• Biliary excretion: Some drugs are excreted unchanged in bile

Assessing Liver Function:

The Child-Pugh score is commonly used to classify liver disease severity and guide dosing:

Parameter	1 Point	2 Points	3 Points
Bilirubin (μmol/L)	<34	34-50	>50
Albumin (g/L)	>35	28-35	<28
INR	<1.7	1.7-2.3	>2.3
Ascites	Absent	Mild	Moderate/severe
Hepatic encephalopathy	None	Grade 1-2	Grade 3-4

Total score: 5-6 = Child-Pugh A (mild), 7-9 = Child-Pugh B (moderate), 10-15 = Child-Pugh C (severe)

Dosing Adjustments for Liver Disease:

Child-Pugh Class	Liver Function	Dosing Adjustment	Examples
A (5-6 points)	Mild impairment	Usually no adjustment needed, but monitor closely	Most drugs metabolized by phase II reactions
B (7-9 points)	Moderate impairment	Reduce dose by 25-50% or increase dosing interval	Drugs with high hepatic extraction (e.g., lidocaine, propranolol)
C (10-15 points)	Severe impairment	Avoid if possible; if essential, reduce dose by 50-75% and extend interval	Drugs with low therapeutic index (e.g., acetaminophen, opioids)

Drug-Specific Considerations:

• Acetaminophen:
  • Maximum daily dose should be reduced to 2-3 g/day in liver disease
  • Avoid in alcoholic liver disease due to increased toxicity risk
• Opioids:
  • Metabolized by liver; accumulate in hepatic impairment
  • Start with 25-50% of normal dose and titrate carefully
  • Monitor for signs of toxicity (respiratory depression, sedation)
• Benzodiazepines:
  • Oxidative metabolism impaired in liver disease
  • Avoid long-acting agents (e.g., diazepam, chlordiazepoxide)
  • Prefer lorazepam or oxazepam (metabolized by conjugation)
• Statins:
  • All statins have some hepatic metabolism
  • Avoid in acute liver disease
  • Use lowest effective dose in chronic liver disease
• Anticoagulants:
  • Warfarin metabolism affected; increased INR sensitivity
  • DOACs (e.g., rivaroxaban, apixaban) require caution
  • Monitor coagulation parameters closely

Monitoring Parameters:

• Liver function tests (AST, ALT, bilirubin, albumin, INR)
• Drug levels for narrow therapeutic index medications
• Signs of hepatic encephalopathy (confusion, asterixis)
• Signs of drug toxicity (specific to each medication)

Alternative Routes of Administration:

For patients with severe liver disease, consider:

• Topical formulations to bypass liver metabolism
• Subcutaneous or intramuscular routes for some medications
• Transdermal patches for select drugs
• Inhaled medications when appropriate